SCHEMBL9824503

SCHEMBL9824503

COc1ccc(/C=C/c2ccccc2)c(CC(C)NCCc2ccc(OC)c(OC)c2)c1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.49
MAPT P10636 3/20 0.48
CYP1A1 P04798 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP1B1 Q16678 2/20 0.48
KCNH2 Q12809 1/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
SIGMAR1 Q99720 2/20 0.44
ADRB2 P07550 1/20 0.43
MEN1 O00255 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10759050 1.00 SLC2A1 (0.49) SLC2A1MAPTCYP1A1CYP1A2CYP1B1
SCHEMBL9824630 1.00 SLC2A1 (0.49) SLC2A1MAPTCYP1A1CYP1A2CYP1B1
Hydrochloric Acid SCHEMBL9824621 0.99 SLC2A1 (0.48) SLC2A1MAPTCYP1A1CYP1A2CYP1B1
Hydrochloric Acid SCHEMBL9824367 0.99 SLC2A1 (0.48) SLC2A1MAPTCYP1A1CYP1A2CYP1B1
SCHEMBL9824584 0.94 SIGMAR1 (0.52) SLC2A1MAPTCYP1A1CYP1A2CYP1B1
SCHEMBL9824510 0.94 SIGMAR1 (0.52) SLC2A1MAPTCYP1A1CYP1A2CYP1B1
SCHEMBL9824488 0.91 MAPT (0.48) SLC2A1MAPTCYP1A1CYP1A2CYP1B1
SCHEMBL9824483 0.91 MAPT (0.48) SLC2A1MAPTCYP1A1CYP1A2CYP1B1
Oxalic Acid SCHEMBL9824967 0.89 MAPT (0.51) MAPTCYP1A1CYP1A2CYP1B1KCNH2
SCHEMBL9824627 0.88 SLC2A1 (0.50) SLC2A1MAPTCYP1A1CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0250254-B1 CIS & TRANS STILBENES AND THEIR COMPOSITION FOR THE TREATMENT OF HYPERTENSION McNeilab, Inc. (US) 1991-06-19 EP claimed
EP-0250254-A1 Cis & trans stilbenes and their composition for the treatment of hypertension McNeilab, Inc. (US) 1987-12-23 EP claimed
EP-0250254-B1 CIS & TRANS STILBENES AND THEIR COMPOSITION FOR THE TREATMENT OF HYPERTENSION McNeilab, Inc. (US) 1991-06-19 EP disclosed
EP-0250254-A1 Cis & trans stilbenes and their composition for the treatment of hypertension McNeilab, Inc. (US) 1987-12-23 EP disclosed